关注公众号

关注公众号

手机扫码查看

手机查看

干货收藏:CAR-T细胞疗法「图鉴」

上海玮驰仪器有限公司
2022.10.14

···点击左上方蓝字 · 关注上海玮驰···


9a4aa2596432cff3ebd1aa899d3acd19.png

27e045a16f7b54b257a72b0c7496002c.pngec279465012b310b6c56e5e7a69a2c8b.pngc9ef633fc750cc2f454e405019fd33d1.pngb96b3dc4128a120fc812d775429dac48.pngba9d918787e618efaf774e7e559c6c1c.png91eb78bd933cd73fe3d83fa9551e203f.pngba3caaace523fdfcab0946c70027427c.png

来源:医药魔方媒体

* 推文用于传递知识,如有版权等疑问,请联系我们。


- 上下滑动查看参考资料 - [1]Robbie G. Majzner, et al. Clinical lessons learned from the first leg of the CAR T cell journey. Nature Medicine. (2019)  [2]Roddie, C., et al. Manufacturing chimeric antigen receptor T cells: issues and challenges. Cytotherapy. (2019)[3]Rebecca C. Larson, et al. Recent advances and discoveries in the mechanisms and functions of CAR T cells. (2021)[4]Robert C. Sterner, et al. CAR-T cell therapy: current limitations and potential strategies. Blood Cancer Journal. (2021)  [5]Andrew J. Hou, et al. Navigating CAR-T cells through the solid-tumour microenvironment. Nature Reviews Drug Discovery. (2021)  [6]S. Depil, et al. ‘Off-the-shelf’ allogeneic CAR T cells: development and challenges. Nature Reviews Drug Discovery . (2020)  

往期精彩:

销售咨询张经理:15895555869a984c9a434b7bf05a87347e1e4541b51.jpg技术咨询赵经理:13162237306af6f5cab54f20eac9ff4e8ed87d778e2.jpg渠道合作顾经理:13564627120d202ed8a8987aafee4fdb3e3905618bb.jpg

d7897ded78c5b7f077056df1c283b8de.png

推荐
关闭